CLSI’s FAST International Program Welcomes Australian and Canadian Startups and Emerging Companies
CLSI’s FAST International program is in full swing this fall, with partnerships serving Australian and Canadian startups and emerging companies. The program helps non-U.S.-based early-stage life science companies build successful business strategies and gain commercial footholds in U.S. markets.
Earlier this month, in a new partnership with Trade & Investment Queensland (TIQ) and Life Sciences Queensland (LSQ), CLSI provided advisory services to five Australian emerging life science companies who have a demonstrated interest in U.S. markets. The FAST TIQ program combined in-person and remote advisory sessions with in-market sessions on the U.S. regulatory and reimbursement landscapes with in-market sessions on the U.S. regulatory and reimbursement landscapes. Read the press release here.
For the second year in a row, CLSI is partnering with the Canadian Technology Accelerator (CTA) San Francisco – Life Sciences to deliver a 12-week winter program that will provide five Canadian early-stage companies with customized mentorship and in-market programming to advance their business strategies. The CTA In Market Program kicked off this month, and will culminate with the Canadian companies presenting with FAST Bay Area Companies at the second FAST International Showcase on December 10.
Like the Bay Area FAST program, FAST International taps the deep experience of CLSI’s Advisory Network of over 380 Bay Area industry veterans to provide commercialization strategy for early-stage life science entrepreneurs. The Network is comprised predominantly of CEOs and other senior executives across multiple functional areas and industry segments. In a variation of this model, FAST Translational, CLSI’s advisory services are being offered to researchers who are seeking commercial spin-outs with strong U.S. market viability.